Schamroth Michael
Director at BIOSPECIFICS TECHNOLOGIES CORP
- Sold, on record
- $1.2M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Nov 24, 2014
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- BIOSPECIFICS TECHNOLOGIES CORPDirector
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPUnusualMar 17, 2008 2008
Sold 50,000 shares at $11.90 ($595k)
Schamroth Michael, Director
Sold 36.5% of holdings ($1.6M position)86,800 shares leftFirst sale on recordFiling
- 2 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not statedNov 14, 2014 +2433 days
Sold 5,200 shares at $39.20 ($204k)
Schamroth Michael, Director
Sold 11.6% of holdings ($1.8M position)39,800 shares leftFirst sale on recordFiling
- 3 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not statedNov 17, 2014 +3 days
Sold 301 shares at $39.00 ($12k)
Schamroth Michael, Director
Sold 0.8% of holdings ($1.6M position)39,499 shares leftFiling
- 4 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not statedNov 19, 2014 +2 days
Sold 5,000 shares at $39.10 ($196k)
Schamroth Michael, Director
Sold 12.7% of holdings ($1.5M position)34,499 shares leftFiling
- 5 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not statedNov 24, 2014 +5 days
Sold 4,499 shares at $39.36 ($177k)
Schamroth Michael, Director
Sold 13% of holdings ($1.4M position)30,000 shares left0.9x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 24, 2014 | Nov 25, 2014 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 4,499 | $177k | 13.0% | Plan not stated | SEC |
| Nov 19, 2014 | Nov 21, 2014 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 5,000 | $196k | 12.7% | Plan not stated | SEC |
| Nov 17, 2014 | Nov 19, 2014 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 301 | $12k | 0.8% | Plan not stated | SEC |
| Nov 14, 2014 | Nov 14, 2014 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 5,200 | $204k | 11.6% | Plan not stated | SEC |
| Mar 17, 2008 | Mar 26, 2008 | BIOSPECIFICS TECHNOLOGIES CORP | Director | Form 4 sale | 50,000 | $595k | 36.5% | Unusual | SEC |